Skip to main content
[Preprint]. 2023 Jan 31:rs.3.rs-2522094. [Version 1] doi: 10.21203/rs.3.rs-2522094/v1

Table 2.

PROs measures included in trial

Measures Description Clinical Cut-Offs
Primary
 PRO-CTCAEs19 5 items (related to VR use) with option to add items, 5-point Likert scale or 0/1 for absent/present 1 = mild
2 = moderate
3 = severe
4 = life-threatening
5 = death
Secondary
 NCCN Distress Thermometer20 1 item, 11-point Likert scale with accompanying Problem List ≥ 5 = moderate-severe
 STAI-6 (S-scale)21,22 6 items from S-scale, 4-item Likert scale (total score converted to range from 20 to 80) ≥ 40 = clinically significant
Exploratory
 UCLA Loneliness Scale23,24 20 items, 4-point Likert scale 20 to 34 = low
35 to 49 = moderate
50 to 64 = moderately high
65 to 80 = high
 COST Questionnaire25 11 items, 5-point Likert scale not established
 ADNM-2026 Stressor & Item lists, 4-point Likert scale ≥ 47.5 = high risk

Abbreviations: PRO-CTCAEs: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; AE: adverse event; STAI-6: State-Trait Anxiety Inventory 6-item; S-scale: “state” anxiety subscale of STAI-6; UCLA: University of California – Los Angeles; COST: Comprehensive Score for Financial Toxicity; ADNM-20: Adjustment Disorder New Module – 20